441 related articles for article (PubMed ID: 25553994)
21. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.
Kim YJ; Kim SI; Hong KW; Kim YR; Park YJ; Kang MW
J Korean Med Sci; 2012 May; 27(5):471-5. PubMed ID: 22563209
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors, Clinical Presentation, and Outcome of
Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
[TBL] [Abstract][Full Text] [Related]
23. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
24. Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
Choi SH; Cho EB; Chung JW; Lee MK
J Infect Chemother; 2019 Jan; 25(1):6-11. PubMed ID: 30342838
[TBL] [Abstract][Full Text] [Related]
25. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Nazer LH; Rihani S; Hawari FI; Le J
Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
[TBL] [Abstract][Full Text] [Related]
26. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
[TBL] [Abstract][Full Text] [Related]
27. Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.
Batirel A; Balkan II; Karabay O; Agalar C; Akalin S; Alici O; Alp E; Altay FA; Altin N; Arslan F; Aslan T; Bekiroglu N; Cesur S; Celik AD; Dogan M; Durdu B; Duygu F; Engin A; Engin DO; Gonen I; Guclu E; Guven T; Hatipoglu CA; Hosoglu S; Karahocagil MK; Kilic AU; Ormen B; Ozdemir D; Ozer S; Oztoprak N; Sezak N; Turhan V; Turker N; Yilmaz H
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1311-22. PubMed ID: 24532009
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
29. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia.
Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL;
J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749
[TBL] [Abstract][Full Text] [Related]
30. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
[TBL] [Abstract][Full Text] [Related]
31. Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology.
Wang X; Zhang L; Sun A; Yang X; Sang W; Jiang Y; Cheng J; Wang J; Zhou M; Chen B; Ouyang J
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1073-1081. PubMed ID: 28101785
[TBL] [Abstract][Full Text] [Related]
32. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC
J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
Kumar A; Randhawa VS; Nirupam N; Rai Y; Saili A
J Infect Dev Ctries; 2014 Aug; 8(8):1049-54. PubMed ID: 25116673
[TBL] [Abstract][Full Text] [Related]
35. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
[No Abstract] [Full Text] [Related]
36. Early Intravenous Colistin Therapy as a Favorable Prognostic Factor for 28-day Mortality in Patients with CRAB Bacteremia: a Multicenter Propensity Score-Matching Analysis.
Kim T; Park KH; Yu SN; Park SY; Park SY; Lee YM; Jeon MH; Choo EJ; Kim TH; Lee MS; Lee E
J Korean Med Sci; 2019 Oct; 34(39):e256. PubMed ID: 31602826
[TBL] [Abstract][Full Text] [Related]
37. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.
Du X; Xu X; Yao J; Deng K; Chen S; Shen Z; Yang L; Feng G
Am J Infect Control; 2019 Sep; 47(9):1140-1145. PubMed ID: 31003750
[TBL] [Abstract][Full Text] [Related]
38. Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
An JH; Kim YH; Moon JE; Jeong JH; Kim SH; Kang SJ; Park KH; Jung SI; Jang HC
Am J Infect Control; 2017 Jun; 45(6):667-672. PubMed ID: 28242072
[TBL] [Abstract][Full Text] [Related]
39. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
40. Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.
Yang YS; Lee YT; Tsai WC; Kuo SC; Sun JR; Yang CH; Chen TL; Lin JC; Fung CP; Chang FY
BMC Infect Dis; 2013 Jul; 13():311. PubMed ID: 23841753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
